138 related articles for article (PubMed ID: 21395654)
21. The relative lung and systemic bioavailability of terbutaline following nebulisation in non-invasively ventilated patients.
Abdelrahim ME; Plant PK; Chrystyn H
Int J Pharm; 2011 Nov; 420(2):313-8. PubMed ID: 21944891
[TBL] [Abstract][Full Text] [Related]
22. Does the mode of inhalation affect the bronchodilator response in patients with severe COPD?
Eiser NM; Phillips C; Wooler PA
Respir Med; 2001 Jun; 95(6):476-83. PubMed ID: 11421505
[TBL] [Abstract][Full Text] [Related]
23. Quantification of terbutaline in urine by enzyme-linked immunosorbent assay and capillary electrophoresis after oral and inhaled administrations.
Roig M; Bergés R; Ventura R; Fitch KD; Morton AR; Segura J
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Mar; 768(2):315-24. PubMed ID: 11888060
[TBL] [Abstract][Full Text] [Related]
24. Use of functional respiratory imaging to characterize the effect of inhalation profile and particle size on lung deposition of inhaled corticosteroid/long-acting β2-agonists delivered via a pressurized metered-dose inhaler.
Van Holsbeke C; De Backer J; Vos W; Marshall J
Ther Adv Respir Dis; 2018; 12():1753466618760948. PubMed ID: 29499614
[TBL] [Abstract][Full Text] [Related]
25. Volumatic usage: some generic salbutamol metered dose inhalers can be used.
Chege JK; Chrystyn H
Thorax; 1994 Nov; 49(11):1162-3. PubMed ID: 7831635
[TBL] [Abstract][Full Text] [Related]
26. Effect of a spacer on total systemic and lung bioavailability in healthy volunteers and in vitro performance of the Symbicort
Gillen M; Forte P; Svensson JO; Lamarca R; Burke J; Rask K; Larsdotter Nilsson U; Eckerwall G
Pulm Pharmacol Ther; 2018 Oct; 52():7-17. PubMed ID: 30077809
[TBL] [Abstract][Full Text] [Related]
27. Relative bioavailability of salbutamol to the lung following inhalation via a novel dry powder inhaler and a standard metered dose inhaler.
Hindle M; Peers EM; Parry-Billings M; Chrystyn H
Br J Clin Pharmacol; 1997 Mar; 43(3):336-8. PubMed ID: 9088593
[TBL] [Abstract][Full Text] [Related]
28. Investigations of an optimal inhaler technique with the use of urinary salbutamol excretion as a measure of relative bioavailability to the lung.
Hindle M; Newton DA; Chrystyn H
Thorax; 1993 Jun; 48(6):607-10. PubMed ID: 8346489
[TBL] [Abstract][Full Text] [Related]
29. Effect of terbutaline on mucociliary clearance in asthmatic and healthy subjects after inhalation from a pressurised inhaler and a dry powder inhaler.
Mortensen J; Groth S; Lange P; Hermansen F
Thorax; 1991 Nov; 46(11):817-23. PubMed ID: 1771605
[TBL] [Abstract][Full Text] [Related]
30. Salbutamol relative lung and systemic bioavailability of large and small spacers.
Mazhar SH; Chrystyn H
J Pharm Pharmacol; 2008 Dec; 60(12):1609-13. PubMed ID: 19000365
[TBL] [Abstract][Full Text] [Related]
31. Terbutaline Accumulates in Blood and Urine after Daily Therapeutic Inhalation.
Krogh N; Rzeppa S; Dyreborg A; Dehnes Y; Hemmersbach P; Backer V; Hostrup M
Med Sci Sports Exerc; 2017 Jun; 49(6):1236-1243. PubMed ID: 28072631
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics and relative bioavailability of salbutamol metered-dose inhaler in healthy volunteers.
Du XL; Zhu Z; Fu Q; Li DK; Xu WB
Acta Pharmacol Sin; 2002 Jul; 23(7):663-6. PubMed ID: 12100764
[TBL] [Abstract][Full Text] [Related]
33. Dose potency relationship of terbutaline inhaled via Turbuhaler or via a pressurized metered dose inhaler.
Ekström T; Andersson AC; Skedinger M; Lindbladh C; Ståhl E
Ann Allergy Asthma Immunol; 1995 Apr; 74(4):328-32. PubMed ID: 7719894
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of Salbutamol Delivered from the Unit Dose Dry Powder Inhaler: Comparison with the Metered Dose Inhaler and Diskus Dry Powder Inhaler.
Moore A; Riddell K; Joshi S; Chan R; Mehta R
J Aerosol Med Pulm Drug Deliv; 2017 Jun; 30(3):164-172. PubMed ID: 28170282
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics of glycopyrronium/formoterol fumarate dihydrate delivered via metered dose inhaler using co-suspension delivery technology in patients with moderate-to-very severe COPD.
Ferguson GT; Rodriguez-Roisin R; Reisner C; Maes A; Siddiqui S; Martin UJ
Int J Chron Obstruct Pulmon Dis; 2018; 13():945-953. PubMed ID: 29606861
[TBL] [Abstract][Full Text] [Related]
36. The inhalation device influences lung deposition and bronchodilating effect of terbutaline.
Borgström L; Derom E; Ståhl E; Wåhlin-Boll E; Pauwels R
Am J Respir Crit Care Med; 1996 May; 153(5):1636-40. PubMed ID: 8630614
[TBL] [Abstract][Full Text] [Related]
37. Comparison of terbutaline and placebo from a pressurised metered dose inhaler and a dry powder inhaler in a subgroup of patients with asthma.
Selroos O; Löfroos AB; Pietinalho A; Riska H
Thorax; 1994 Dec; 49(12):1228-30. PubMed ID: 7878558
[TBL] [Abstract][Full Text] [Related]
38. Relative lung deposition of salbutamol following inhalation from a spacer and a Sidestream jet nebulizer following an acute exacerbation.
Mazhar SH; Ismail NE; Newton DA; Chrystyn H
Br J Clin Pharmacol; 2008 Mar; 65(3):334-7. PubMed ID: 17922883
[TBL] [Abstract][Full Text] [Related]
39. Systemic Exposures of Fluticasone Propionate and Salmeterol Following Inhalation via Metered Dose Inhaler with the Mini Spacer Compared with the Aerochamber Plus Spacer.
Mehta R; Montembault M; Warren F; Gupta A; Brealey N; Moore A
J Aerosol Med Pulm Drug Deliv; 2016 Aug; 29(4):386-92. PubMed ID: 26824933
[TBL] [Abstract][Full Text] [Related]
40. Lung deposition and systemic bioavailability of different aerosol devices with and without humidification in mechanically ventilated patients.
Moustafa IOF; Ali MRA; Al Hallag M; Rabea H; Fink JB; Dailey P; Abdelrahim MEA
Heart Lung; 2017; 46(6):464-467. PubMed ID: 28882385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
